A Phase III Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients 1 to 11 Years of Age
Latest Information Update: 18 Jul 2024
At a glance
- Drugs Esomeprazole (Primary)
- Indications Erosive oesophagitis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms SOLACE
- Sponsors AstraZeneca; AstraZeneca AB
- 20 Mar 2023 This trial has been completed in suspended in Spain, according to the European Clinical Trials Database record.
- 20 Mar 2023 This trial has been completed in suspended in Spain, according to the European Clinical Trials Database record.
- 09 Sep 2022 Planned End Date changed from 3 Sep 2026 to 6 Nov 2026.